april
million
patient
world
test
posit
coronaviru
die
account
case
fatal
rate
mexico
accord
offici
statist
april
case
confirm
death
case
fatal
rate
estim
howev
may
reflect
final
fatal
risk
among
confirm
patient
base
crosssect
count
diagnos
deceas
patient
therefor
adjust
time
exposur
rightcensorship
paper
estim
fatal
risk
base
surviv
analysi
method
calcul
individuallevel
data
symptomat
patient
confirm
recent
releas
mexican
ministri
health
estim
fatal
risk
day
onset
symptom
ci
fatal
risk
sharpli
rise
age
significantli
increas
male
individu
comorbid
depend
diseas
two
reason
may
explain
high
relat
fatal
risk
observ
mexico
despit
younger
age
structur
high
select
selfselect
test
high
preval
chronicdegen
diseas
two
import
characterist
differenti
current
pandem
recent
previou
outbreak
sar
coronaviru
influenza
high
rate
transmiss
appar
higher
fatal
rate
liu
et
al
surveil
rapid
spread
new
infect
repres
challeng
time
calcul
epidemiolog
demograph
paramet
one
challeng
estim
fatal
risk
april
million
patient
world
test
posit
coronaviru
die
account
fatal
mexico
accord
offici
statist
april
case
confirm
death
fatal
de
salud
howev
estim
may
reflect
final
fatal
rate
among
confirm
patient
given
obtain
cumul
daili
count
confirm
patient
relat
death
take
consider
differ
exposur
time
current
confirm
patient
therefor
may
bias
rightcensorship
particularli
countri
earli
stage
evolut
epidem
mexico
accumul
larg
proport
recent
case
order
obtain
unbias
estim
fatal
risk
necessari
consid
patient
time
exposur
onset
symptom
correct
bias
exposur
associ
rightcensorship
may
achiev
usual
method
surviv
analysi
method
howev
requir
individuallevel
data
inform
date
onset
symptom
date
death
deceas
basic
demograph
inform
except
hand
clinic
studi
shi
et
al
zha
et
al
zhou
et
al
data
characterist
unavail
moment
countri
case
mexico
feder
ministri
health
de
salud
recent
made
public
individuallevel
data
patient
attend
medic
unit
across
countri
test
posit
inform
updat
daili
basi
allow
us
estim
fatal
risk
patient
use
surviv
analysi
well
possibl
effect
basic
demograph
factor
presenc
comorbid
type
medic
institut
risk
death
analysi
base
patient
test
posit
mexico
subset
larger
dataset
patient
relat
symptom
sought
attent
medic
unit
test
posit
neg
case
pend
case
result
inform
patient
report
daili
basi
de
salud
make
integr
data
avail
public
updat
daili
use
data
set
releas
april
first
relev
characterist
dataset
inclus
date
onset
symptom
death
occur
case
basic
demograph
trait
age
sex
patient
also
avail
data
includ
inform
well
preexist
comorbid
high
blood
pressur
diabet
chronic
obstruct
pulmonari
diseas
copd
asthma
immunosuppress
cardiovascular
diseas
obes
chronic
kidney
diseas
ckd
smoke
medic
attent
mexico
highli
segment
accord
type
medic
institut
data
includ
inform
type
institut
patient
receiv
attent
addit
identifi
indic
whether
medic
unit
monitor
health
unit
respiratori
diseas
usmer
sampl
clinic
hospit
part
system
epidemiolog
surveil
implement
mexican
govern
monitor
incid
infecti
respiratori
diseas
use
data
estim
fatal
risk
associ
use
surviv
analysi
method
first
use
lifet
method
chiang
miller
estim
cumul
proport
relat
death
differ
durat
sinc
onset
symptom
defin
durat
day
sinc
onset
symptom
obtain
estim
overal
fatal
risk
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
second
estim
piecewis
exponenti
proport
hazard
model
ph
model
blossfeld
et
al
estim
independ
effect
demograph
characterist
comorbid
type
health
institut
fatal
hazard
associ
introduc
time
segment
correspond
weekli
time
period
sinc
onset
symptom
week
one
five
ph
model
also
includ
gamma
frailti
term
control
individu
heterogen
reduc
possibl
bia
aris
incomplet
model
specif
due
unobserv
variabl
paik
et
al
gutierrez
tabl
present
descript
statist
patient
median
age
male
three
frequent
comorbid
high
blood
pressur
obes
diabet
comorbid
asthma
cardiovascular
diseas
copd
immun
suppress
chronic
liver
diseas
also
frequent
among
patient
preval
overal
half
patient
present
comorbid
one
comorbid
two
comorbid
three
almost
half
patient
come
medic
unit
integr
sentinel
surveil
model
sampl
usmer
attend
medic
unit
distribut
accord
type
medic
institut
show
half
patient
receiv
attent
imssbienestar
ministri
health
imss
privat
clinic
hospit
issst
type
servic
account
small
fraction
case
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
figur
present
cumul
proport
death
patient
accord
number
day
elaps
sinc
onset
symptom
curv
estim
use
lifet
method
correct
rightcensorship
gener
curv
show
pattern
acceler
week
decreas
day
estim
death
risk
day
tabl
ci
risk
higher
male
ci
femal
ci
risk
also
increas
sharpli
presenc
comorbid
patient
comorbid
estim
death
risk
day
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
one
comorbid
two
comorbid
three
comorbid
also
posit
associ
age
patient
less
year
age
estim
death
risk
age
risk
year
risk
estim
base
bivari
associ
may
reflect
effect
correl
factor
control
estim
order
evalu
independ
effect
factor
estim
piecewis
exponenti
hazard
model
risk
relat
death
tabl
explain
methodolog
section
model
includ
gamma
term
unobserv
heterogen
may
help
reduc
bias
associ
unobserv
variabl
hazard
ratio
confirm
timedepend
pattern
observ
descript
analysi
compar
first
week
symptom
estim
hazard
rate
increas
second
week
third
week
reduc
half
hr
fourth
week
almost
hr
fifth
week
higher
risk
relat
fatal
among
confirm
male
patient
also
corrobor
model
even
control
age
comorbid
estim
death
hazard
higher
male
ci
effect
age
also
posit
statist
signific
compar
patient
year
age
estim
hazard
death
higher
patient
year
ci
lower
patient
year
ci
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
preexist
comorbid
affect
hazard
relat
death
model
identifi
signific
effect
asthma
cardiovascular
diseas
smoke
comorbid
contrast
high
blood
pressur
increas
estim
hazard
ci
immun
suppress
ci
diabet
ci
copd
ci
obes
ci
chronic
liver
diseas
ci
signific
interact
effect
associ
presenc
two
preexist
condit
final
estim
fatal
hazard
lower
patient
receiv
attent
nonusm
unit
ci
may
reflect
neg
select
patient
receiv
attent
usm
unit
gener
equip
nonusm
unit
therefor
may
concentr
sever
case
select
may
also
explain
higher
fatal
risk
patient
attend
imss
compar
imssbienestarssa
issst
privat
institut
howev
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
differ
qualiti
procedur
attent
institut
discard
particularli
explain
larger
reduct
fatal
hazard
privat
institut
ci
paper
appli
surviv
analysi
method
estim
fatal
risk
associ
risk
factor
symptomat
confirm
patient
mexico
use
individuallevel
data
recent
releas
ministri
health
fatal
risk
day
onset
symptom
estim
use
lifet
method
figur
consider
higher
obtain
simpl
ratio
death
vs
confirm
case
differ
mostli
explain
rightcensorship
crosssect
data
consider
proport
confirm
patient
still
risk
death
eventu
die
current
consid
calcul
crosssect
fatal
rate
fatal
risk
estim
lifet
method
introduc
correct
bia
therefor
may
closer
final
fatal
risk
symptomat
confirm
patient
mexico
estim
fatal
hazard
symptomat
confirm
patient
higher
second
week
onset
symptom
also
higher
male
sharpli
increas
age
preexist
certain
comorbid
chronic
kidney
diseas
copd
obes
diabet
immun
suppress
hypertens
also
risk
factor
significantli
increas
fatal
hazard
signific
effect
associ
cardiovascular
diseas
asthma
smoke
result
must
taken
caution
repres
subset
case
symptom
seriou
enough
seek
medic
attent
test
posit
presenc
viru
mexico
adopt
polici
restrict
test
case
compar
countri
signific
number
case
mexico
one
lowest
number
test
per
thousand
versu
median
per
thousand
group
countri
updat
inform
april
therefor
select
confirm
case
among
seriou
symptom
like
higher
countri
select
along
high
preval
comorbid
among
adult
popul
might
explain
high
fatal
risk
observ
mexico
sum
result
may
best
interpret
reflect
fatal
risk
patient
seriou
symptom
seek
medic
attent
mexico
caution
must
exercis
extrapol
overal
infect
popul
countri
differ
epidemiolog
profil
test
polici
http
ourworldindataorgcovidtest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
